Johnson & Johnson (NYSE:JNJ)

161.25
Delayed Data
As of Apr 09
 -1.72 / -1.06%
Today’s Change
133.65
Today|||52-Week Range
173.65
+2.46%
Year-to-Date
US Indexes End with Gains Friday
7:51am / GuruFocus News - Paid Partner Content
3 Dividend Stocks That Should Pay You the Rest of Your Life
Apr 04 / MotleyFool.com - Paid Partner Content
3 Stocks That Could Suffer if Biden Gives In to This Pressure
Apr 10 / MotleyFool.com - Paid Partner Content
Is the Market For a Flu Vaccine Disappearing?
Apr 04 / MotleyFool.com - Paid Partner Content
3 Biotech Stocks With Big Catalysts Around the Corner
Apr 10 / MotleyFool.com - Paid Partner Content
3 Dividend Stocks That Are Perfect for Retirement
Apr 04 / MotleyFool.com - Paid Partner Content
ImmunityBio (IBRX) Reports Positive COVID-19 Vaccine Data
Apr 09 / Zacks.com - Paid Partner Content
These 3 Vaccine Stocks May Be Post-Pandemic Winners
Apr 04 / MotleyFool.com - Paid Partner Content
Why Moderna Stock Is Jumping Today
Apr 09 / MotleyFool.com - Paid Partner Content
New to the Stock Market? 3 Investments You Can't Go Wrong With
Apr 04 / MotleyFool.com - Paid Partner Content
Pharma Stock Roundup: FDA Decision Delays for PFE, LLY, ABBV, AZN Vaccine Woes
Apr 09 / Zacks.com - Paid Partner Content
Here's the Next Catalyst for Moderna Shares
Apr 03 / MotleyFool.com - Paid Partner Content
Newman & Schimel, LLC Buys Berkshire Hathaway Inc, iShares Core S&P Total U.S. ...
Apr 08 / GuruFocus News - Paid Partner Content
11 Words From President Biden That Frighten Big Pharma
Apr 03 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: ACAD Down on CRL, EBS Gets Additional Order & Other Updates
Apr 07 / Zacks.com - Paid Partner Content
Got $1,400? Here's 3 Stocks to Buy and Hold for the Long Term
Apr 03 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: ACAD Down on CRL, EBS Gets Additional Order & Other Updates
Apr 07 / Zacks.com - Paid Partner Content
This Could Be a New Billion-Dollar Market for Moderna
Apr 03 / MotleyFool.com - Paid Partner Content
AstraZeneca (AZN) COVID-19 Vaccine Dosing Halted in Kids Study
Apr 07 / Zacks.com - Paid Partner Content
Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?
Apr 02 / Zacks.com - Paid Partner Content
Roche, Merck and J&J: Kings of R&D Spenders in 2020
Apr 07 / GuruFocus News - Paid Partner Content
When Will Johnson & Johnson Start to Profit From Its COVID Vaccine?
Apr 02 / MotleyFool.com - Paid Partner Content
Catalent (CTLT) Expands Deal With Moderna for COVID-19 Vaccine
Apr 07 / Zacks.com - Paid Partner Content
Why Emergent BioSolutions Crashed Today
Apr 01 / MotleyFool.com - Paid Partner Content
3 Robinhood Stocks You Can Buy and Hold Forever
Apr 07 / MotleyFool.com - Paid Partner Content
Did Pfizer Just Leap Ahead of Moderna in This Key Market?
Apr 01 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Pfizer, Johnson & Johnson, Delta Air Lines, Southwest Airlines and United Airlines
Apr 06 / Zacks.com - Paid Partner Content
How Does the AstraZeneca Vaccine Measure Up to Rivals?
Apr 01 / MotleyFool.com - Paid Partner Content
3 Top Dividend Stocks to Buy in April
Apr 06 / MotleyFool.com - Paid Partner Content
These 3 Stocks Will Make You A Fortune If They Succeed
Apr 01 / MotleyFool.com - Paid Partner Content
Is Johnson & Johnson a Buy in April?
Apr 06 / MotleyFool.com - Paid Partner Content
Forget the Vaccine Problems, AstraZeneca Stock Can Still Make You Rich
Apr 01 / MotleyFool.com - Paid Partner Content
Johnson & Johnson Given Control of Emergent BioSolutions Factory That Botched Its Coronavirus Vaccine
Apr 05 / MotleyFool.com - Paid Partner Content
3 Dividend Aristocrats to Buy and Hold Forever
Apr 01 / MotleyFool.com - Paid Partner Content
CDC's New Guidance Makes the Skyline Sunnier for U.S. Airlines
Apr 05 / Zacks.com - Paid Partner Content
Can AstraZeneca Win in the U.S. COVID Vaccine Market After Its Efficacy Results Fiasco?
Apr 01 / MotleyFool.com - Paid Partner Content
Supernus (SUPN) Receives FDA Approval for ADHD Treatment
Apr 05 / Zacks.com - Paid Partner Content
Pfizer (PFE)/BioNTech COVID-19 Vaccine 100% Effective in Teens
Apr 01 / Zacks.com - Paid Partner Content
Emergent (EBS) Gets Extra $23M for COVID-19 Vaccine Production
Apr 05 / Zacks.com - Paid Partner Content
Pfizer Versus Moderna: Which Is Leading U.S. Vaccine Rollout?
Apr 01 / MotleyFool.com - Paid Partner Content
Company News for Apr 5, 2021
Apr 05 / Zacks.com - Paid Partner Content
Here's How Today's Vaccines Are Holding Up to Strains Right Now
Apr 01 / MotleyFool.com - Paid Partner Content
SpringWorks (SWTX) Begins Dosing in Multiple Myeloma Study
Apr 05 / Zacks.com - Paid Partner Content
This Company May Be Next to Enter the U.S. Vaccine Market
Apr 01 / MotleyFool.com - Paid Partner Content
Better Buy for 2021: Pfizer or Gilead?
Apr 05 / MotleyFool.com - Paid Partner Content
Vaccine Makers vs. COVID Variants: What Are Their Strategies?
Mar 31 / MotleyFool.com - Paid Partner Content
J&J (JNJ) Gets Full Charge of Emergent COVID-19 Vaccine Plant
Apr 05 / Zacks.com - Paid Partner Content
Here's What You Need to Know About COVID Variants' Impact on Vaccine Efficacy
Mar 31 / MotleyFool.com - Paid Partner Content
How the Infrastructure Bill Will Raise Taxes on 3 Big Pharma Stocks
Apr 04 / MotleyFool.com - Paid Partner Content
How AstraZeneca Flubbed Its Better-Than-Expected COVID Vaccine Update
Mar 31 / MotleyFool.com - Paid Partner Content